US Stock MarketDetailed Quotes

CVAC CureVac

Watchlist
  • 3.240
  • -0.010-0.31%
Close Aug 16 16:00 ET
  • 3.240
  • 0.0000.00%
Post 20:01 ET
726.78MMarket Cap-2363P/E (TTM)

CureVac Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CureVac Q2 2024 Earnings Date

Currency：EURAug 15, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.91M
14.44M
+9.52M
Beat Est.
-35.20%
+90.47%
+193.94%
EPS
-0.30
-0.32
-0.02
Miss Est.
-0.40%
-6.67%
-6.28%
Analyst Rating
Buy

Aug 17, 2024

CureVac Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 86.106M--
--2024/Q3-- / 138.328M--
Aug 15, 20242024/Q214.436M / 4.911M--
May 23, 20242024/Q112.373M / 12.889M--
Apr 24, 20242023/Q422.600M / 29.083M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 86.106M--
--2024/Q3-- / 138.328M--
Aug 15, 20242024/Q214.436M / 4.911M--
May 23, 20242024/Q112.373M / 12.889M--
Apr 24, 20242023/Q422.600M / 29.083M--

Unlock Free Earnings Estimates

CureVac Earnings Reports

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 16:32 ET

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 16:27 ET

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    May 23 16:31 ET

  • CureVac | 6-K: Report of foreign private issuer (related to financial reporting)

    May 23 16:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 17, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg